MYC,MYC/BCL2,B

Yanjie Wang1, Donglin Liu1, Xudong Zhang1

  • 1Department of Oncology, Henan Province Lymphoma Treatment Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Cancer medicine
|August 29, 2023
PubMed
概括

过度表达MYC表明大质量扩散大B细胞淋巴瘤 (DLBCL) 的预后不佳. 巩固性放射治疗可以改善这些患者的生存结果.